<?xml version="1.0" encoding="UTF-8"?>
<p>The risk in this case is that payment will be made to develop a vaccine against a possible disease which is never needed to protect against a large scale epidemic of that disease. This phenomenon (possible after-the-fact loss) alone is common to all insurances; many people will pay premiums and collect nothingâ€”but in every time period some people will collect much more than they paid in, and that is the benefit from the insurance. In the case of developing an expensive vaccine that is never used, there is no such offsetting benefit.</p>
